1.
Microsurgery
; 41(5): 503-504, 2021 07.
Article
in English
| MEDLINE | ID: covidwho-1182203
2.
Breast J
; 27(1): 80-81, 2021 01.
Article
in English
| MEDLINE | ID: covidwho-868253
Subject(s)
Breast Neoplasms/surgery , COVID-19 , Critical Pathways , Mammaplasty , Mastectomy/methods , Postoperative Complications/epidemiology , Breast Neoplasms/epidemiology , Breast Neoplasms/pathology , COVID-19/epidemiology , COVID-19/prevention & control , Critical Pathways/organization & administration , Critical Pathways/trends , Decision Making, Shared , Female , Humans , Infection Control/methods , Italy/epidemiology , Mammaplasty/adverse effects , Mammaplasty/methods , Middle Aged , Organizational Innovation , Outcome and Process Assessment, Health Care , SARS-CoV-2 , Time Factors
3.
Ecancermedicalscience
; 14: 1041, 2020.
Article
in English
| MEDLINE | ID: covidwho-611855
ABSTRACT
The onset of the COVID-19 pandemic has changed the face of the treatment of breast cancer and breast reconstruction globally. Mastectomy with immediate implant-based breast reconstruction was on the rise due to advances in meshes and implants. However, due to the prioritisation of the critically ill and diversion of the work force, breast cancer treatment has drastically changed. This is an opinion paper written by the authors with experience and importance in the scenario of breast reconstructive surgery. The authors are from different countries with the COVID-19 pandemic in different stages.
4.
Eur J Surg Oncol
; 46(6): 1194-1195, 2020 Jun.
Article
in English
| MEDLINE | ID: covidwho-248415
5.
Breast J
; 26(7): 1485-1487, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-209936